| Entry |
|
|---|
| Name |
|
|---|
| Formula |
C6496H10000N1704O2038S44
|
|---|
| Exact mass |
145895.8955
|
|---|
| Mol weight |
145985.9612
|
|---|
| Sequence |
(Heavy chain) QVQLVQSGAE VKKPGSSVKV SCKASGGTFS YYWIEWVRQA
PGQGLEWMGE ILPGSGTTNP NEKFKGRVTI TADESTSTAY MELSSLRSED TAVYYCARAD
YYGSDYVKFD YWGQGTLVTV SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT
VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV
EPKSCDKTHT CPPCPAPELL GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF
NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPAPIEKT
ISKAKGQPRE PQVYTLPPSR EEMTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP
PVLDSDGSFF LYSKLTVDKS RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
(Disulfide bridge: 22-96; 149-205; 266-326; 372-430, Dimer: 231; 234)
(Light chain) DIQMTQSPSS LSASVGDRVT ITCKASQHVI THVTWYQQKP
GKAPKLLIYG TSYSYSGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQQ FYEYPLTFGG
GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ
ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: 23-88; 134-194; H225-L214, Dimer) |
|---|
| Type |
Peptide |
|---|
| Class |
Other
DG02019 Interleukin inhibitor
|
|---|
| Efficacy |
Antiasthmatic, Anti-IL-9 antibody |
|---|
| Comment |
Monoclonal antibody
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokines
Interleukins
IL9
D09897 Enokizumab (USAN/INN)
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
